Abstract
We report 8 cases of coccidioidomycosis associated with ruxolitinib treatment. Among 135 patients living in the coccidioidal-endemic region receiving ruxolitinib, 5 cases were diagnosed after starting and 4 had extrathoracic dissemination. Periodic serological screening while on ruxolitinib is warranted for patients residing in the coccidioidal-endemic region.
Author supplied keywords
Cite
CITATION STYLE
APA
Kusne, Y., Kimes, K. E., Feller, F. F., Patron, R., Banacloche, J. G., Blair, J. E., … Ampel, N. M. (2020). Coccidioidomycosis in Patients Treated with Ruxolitinib. Open Forum Infectious Diseases, 7(6). https://doi.org/10.1093/ofid/ofaa167
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free